EGFR mutations subset in Chinese lung squamous cell carcinoma patients

Research has identified that epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) possess large benefits for adenocarcinoma (ADC), although little benefit for squamous cell carcinoma (SCC). The aim of the present study was to investigate the percentage of patients with SCC with...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ying, Yin, Xin, Wen, Miao-Miao, Zhang, Jiao, Wang, Xue-Jiao, Xia, Jing-Hua, Zhang, Yan-Ning, Zhang, Zhi-Pei, Li, Xiao-Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983943/
https://www.ncbi.nlm.nih.gov/pubmed/29620244
http://dx.doi.org/10.3892/mmr.2018.8859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983943/
https://www.ncbi.nlm.nih.gov/pubmed/29620244
http://dx.doi.org/10.3892/mmr.2018.8859

Ejemplares similares